One of the largest publicly listed ketamine focused clinic operations operating in the United States, Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) has announced a signed licensing partnership agreement with Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954).
The agreement will allow Revitalist to implement the Awakn Life Sciences KARE® protocol for those suffering from Alcohol Use Disorder. The goal is to provide a sustained focus on recovery measures for those seeking relapse prevention.
In January 2022, Awakn’s unique ketamine-assisted therapy for Alcohol Use Disorder was developed and validated in a Phase II a/b trial, with findings published in the American Journal of Psychiatry. Over the six-month posttherapy period, 86% abstinence was achieved versus 2 percent before and 25% in current practice.
The license agreement will see Awakn provide access to the proprietary therapeutics and training by their Subject Matter Experts to the Revitalist providers while Revitalist will pay an annual licensing fee and revenue share for clients seeking services through the partnership.
About Awakn Life Sciences
Awakn Life Sciences Corp. is a biotechnology firm that investigates, creates, and sells medications to cure substance and behavioral addictions.
Awakn’s aim is to develop medicines that can treat the 2.22 million people who suffer from Alcohol Use Disorder (AUD) and have been largely underprescribed thus far. Their objective is to provide immediate treatment for people suffering from addiction by commercializing our research pipeline across several channels.
The US alcohol and drug addiction treatment market is worth $30 billion, with 14,000+ treatment centers generating more than $30 billion in revenue. It is, however, a subpar industry with typical 12-month relapse rates of 75%.
Awakn aims to increase the efficiency and effectiveness of this sector by offering clinic owners with authorized treatment alternatives.
About Reviatlist Lifestyle and Wellness Clinics
Revitalist Lifestyle and Wellness operate one of the largest publicly listed, ketamine-focused clinic operations in the United States.
Each Revitalist Lifesttyle and Wellness clinic provides psychedelic treatment, vitamin infusions, and other lifestyle improvement services courtesy of medical and behavioral specialists.
Revitalist has offered thousands of ketamine injections through its network of nine clinics throughout six states since its inception in 2018. Its founder and CEO, Kathryn Walker, serves as a major psychedelic provider.